000 00658nam a2200109Ia 4500
008 230817s9999 xx 000 0 und d
100 _aRobert J. Fontana et al
245 0 _aEfficacy and Safety of 8 Weeks of Glecaprevir/Pibrentasvir in Treatment-Naïve, HCV-Infected Patients with APRI ≤ 1 in a Single-Arm, Open-Label, Multicenter Study
650 _aComputer science, information & general works
856 _uhttps://new.zodml.org/sites/default/files/2023-07/efficacy_and_safety_of_8_weeks_of_glecaprevir_pibrentasvir_in_treatment-naive_hcv-infected_patients_with_apri_1_in_a_single-arm_open-label_multicenter_study.pdf
942 _cEBK
999 _c33882
_d33882